Catalyst Pharmaceuticals, Inc. (CPRX)
USD 21.4
(-1.88%)
USD 21.4
(-1.88%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 313.67 Million USD | 74.45% |
| 2022 | 179.81 Million USD | 51.17% |
| 2021 | 118.94 Million USD | 16.58% |
| 2020 | 102.03 Million USD | 16.55% |
| 2019 | 87.54 Million USD | 550.83% |
| 2018 | -19.41 Million USD | -42403.02% |
| 2017 | -45.68 Thousand USD | -5.26% |
| 2016 | -43.4 Thousand USD | -25.93% |
| 2015 | -34.46 Thousand USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | -100.0% |
| 2010 | 488.95 Thousand USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 97.96 Million USD | 13.92% |
| 2024 Q1 | 85.98 Million USD | 0.34% |
| 2023 Q4 | 85.7 Million USD | -3.19% |
| 2023 FY | 313.67 Million USD | 74.45% |
| 2023 Q2 | 87.53 Million USD | 16.07% |
| 2023 Q3 | 88.52 Million USD | 1.12% |
| 2023 Q1 | 75.42 Million USD | 52.17% |
| 2022 Q3 | 47.57 Million USD | 4.64% |
| 2022 Q4 | 49.56 Million USD | 4.17% |
| 2022 Q1 | 37.19 Million USD | 20.15% |
| 2022 Q2 | 45.47 Million USD | 22.23% |
| 2022 FY | 179.81 Million USD | 51.17% |
| 2021 Q2 | 31.82 Million USD | 24.67% |
| 2021 Q1 | 25.52 Million USD | -2.38% |
| 2021 Q4 | 30.96 Million USD | 1.03% |
| 2021 FY | 118.94 Million USD | 16.58% |
| 2021 Q3 | 30.64 Million USD | -3.7% |
| 2020 Q3 | 25.43 Million USD | -0.11% |
| 2020 Q1 | 24.98 Million USD | -2.87% |
| 2020 FY | 102.03 Million USD | 16.55% |
| 2020 Q2 | 25.46 Million USD | 1.92% |
| 2020 Q4 | 26.14 Million USD | 2.78% |
| 2019 Q3 | 26.5 Million USD | 7.87% |
| 2019 FY | 87.54 Million USD | 550.83% |
| 2019 Q1 | 10.73 Million USD | 235.62% |
| 2019 Q2 | 24.57 Million USD | 128.9% |
| 2019 Q4 | 25.72 Million USD | -2.96% |
| 2018 Q2 | -3.7 Million USD | -13.68% |
| 2018 Q1 | -3.25 Million USD | 4.28% |
| 2018 FY | -19.41 Million USD | -42403.02% |
| 2018 Q4 | -7.91 Million USD | -74.45% |
| 2018 Q3 | -4.53 Million USD | -22.5% |
| 2017 Q4 | -3.4 Million USD | -25.87% |
| 2017 FY | -45.68 Thousand USD | -5.26% |
| 2017 Q2 | -2.45 Million USD | 12.87% |
| 2017 Q1 | -2.81 Million USD | 0.24% |
| 2017 Q3 | -2.7 Million USD | -10.33% |
| 2016 Q4 | -2.82 Million USD | -13.1% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q3 | -2.49 Million USD | 0.59% |
| 2016 FY | -43.4 Thousand USD | -25.93% |
| 2016 Q2 | -2.5 Million USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 FY | -34.46 Thousand USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | - USD | -100.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q1 | - USD | -100.0% |
| 2011 Q3 | - USD | 0.0% |
| 2010 FY | 488.95 Thousand USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q4 | 488.95 Thousand USD | 0.0% |
| 2009 Q2 | - USD | 100.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q1 | -301.32 Thousand USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 100.0% |
| 2008 Q1 | -179.97 Thousand USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | -160.365% |
| Jaguar Health, Inc. | 7.72 Million USD | -3961.005% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 47339.759% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 6273540.0% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 79.335% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -161.932% |
| ContextLogic Inc. | 59 Million USD | -431.647% |
| MiMedx Group, Inc. | 266.84 Million USD | -17.549% |
| MEI Pharma, Inc. | 49.32 Million USD | -535.903% |
| AlloVir, Inc. | -398 Thousand USD | 78912.06% |
| Novavax, Inc. | 639.93 Million USD | 50.984% |
| Aptorum Group Limited | -1.11 Million USD | 28239.892% |
| Ardelyx, Inc. | 106.66 Million USD | -194.083% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -30.298% |
| Psyence Biomedical Ltd. | -240.00 USD | 130696766.667% |
| Vaxcyte, Inc. | -75 Million USD | 518.229% |
| Precigen, Inc. | 106 Thousand USD | -295816.981% |
| Pharming Group N.V. | 220.1 Million USD | -42.511% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -60807.184% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -30987.413% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -185.749% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 272.91% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 60801.389% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 342.18% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 792.051% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 1526.625% |
| Acelyrin, Inc. | -115 Thousand USD | 272858.261% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 55033.8% |
| Senti Biosciences, Inc. | -2.68 Million USD | 11791.092% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -7643.076% |
| AbCellera Biologics Inc. | 38.02 Million USD | -724.91% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 6637.557% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -261293.333% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -976.838% |
| Chimerix, Inc. | 324 Thousand USD | -96712.346% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -63140.323% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 382626.829% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 1106.402% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 63854.472% |
| Elevation Oncology, Inc. | -39 Thousand USD | 804387.179% |
| Alkermes plc | 1.37 Billion USD | 77.182% |
| Fortress Biotech, Inc. | 57.85 Million USD | -442.188% |
| Fortress Biotech, Inc. | 57.85 Million USD | -442.188% |
| Agenus Inc. | 139.61 Million USD | -124.669% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -1792.212% |
| Dyadic International, Inc. | 922.95 Thousand USD | -33885.549% |
| ImmuCell Corporation | 4.39 Million USD | -7034.935% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -1389.35% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 395.574% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 179502.092% |
| Immix Biopharma, Inc. | -5468.00 USD | 5736603.292% |
| Incyte Corporation | 3.44 Billion USD | 90.883% |
| IO Biotech, Inc. | -756 Thousand USD | 41591.005% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 769.681% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 2448.223% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 709957.88% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 419.366% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 570412.727% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -39011.222% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 59620.304% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -967.384% |
| NextCure, Inc. | -3.68 Million USD | 8614.441% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -1547.177% |
| Onconetix, Inc. | -1.12 Million USD | 27928.401% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 1182.822% |
| Opthea Limited | 21.72 Thousand USD | -1444062.063% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 547272.313% |
| PureTech Health plc | -1.6 Million USD | 19667.81% |
| Pyxis Oncology, Inc. | -2 Million USD | 15783.6% |
| Seer, Inc. | 7.02 Million USD | -4363.811% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 3120903.9% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -3885.161% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 8057.082% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -73879.245% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -201.321% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -131.888% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 423.54% |
| ChromaDex Corporation | 50.78 Million USD | -517.708% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 135303.448% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 504.227% |
| CRISPR Therapeutics AG | 240.95 Million USD | -30.178% |
| Precision BioSciences, Inc. | 40.47 Million USD | -675.035% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 419.542% |
| Innoviva, Inc. | 261.06 Million USD | -20.151% |
| Summit Therapeutics Inc. | -2.05 Million USD | 15401.073% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -7064.733% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -1355.892% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 264822.215% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 218990.308% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -51406.076% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -12086.169% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 618294.718% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 4519.16% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 66199.527% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 3016176.923% |
| Soligenix, Inc. | 97.31 Thousand USD | -322239.715% |
| Century Therapeutics, Inc. | -10.8 Million USD | 3001.952% |
| Kura Oncology, Inc. | -849 Thousand USD | 37046.054% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 567.442% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 213482.313% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -216.716% |
| Autolus Therapeutics plc | -4.86 Million USD | 6544.874% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -657.918% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 186809.524% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -231.147% |
| GRI Bio, Inc. | 10.84 Million USD | -2793.386% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -12249.359% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 3710.821% |
| IGM Biosciences, Inc. | -211.66 Million USD | 248.196% |
| INmune Bio, Inc. | 155 Thousand USD | -202269.032% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -406.421% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 20924.13% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 48472.282% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 1071603.723% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -77927.861% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 15815.03% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 100314.696% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -232.065% |
| Verastem, Inc. | -62 Thousand USD | 506022.581% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -12781.807% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 120280.843% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -10262.471% |
| Histogen Inc. | 3.76 Million USD | -8222.42% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -54340.026% |
| Surrozen, Inc. | -27.23 Million USD | 1251.935% |
| Organovo Holdings, Inc. | -5.38 Million USD | 5920.598% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 26133.464% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 1323.036% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -1464.293% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 15842120.202% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -5070.625% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 467353.579% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -102.642% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -215038.546% |
| Apollomics, Inc. | 127 Thousand USD | -246885.827% |
| Amarin Corporation plc | 165.54 Million USD | -89.483% |
| Mesoblast Limited | -9.81 Million USD | 3295.843% |
| Turnstone Biologics Corp. | 16.5 Million USD | -1800.351% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 383.894% |
| Synaptogenix, Inc. | -6347.00 USD | 4942151.363% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 615143.137% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -94.387% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 82.154% |
| Better Therapeutics, Inc. | -2.72 Million USD | 11594.027% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 379.662% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 7.22% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 2749679.243% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 5110.735% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 28409.747% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -4186.307% |
| Insmed Incorporated | 239.63 Million USD | -30.896% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -8666.685% |
| OmniAb, Inc. | 14.66 Million USD | -2038.624% |
| Alector, Inc. | -95.05 Million USD | 429.997% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -149.697% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 821.699% |
| Zai Lab Limited | 170.9 Million USD | -83.538% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -283.101% |
| Aura Biosciences, Inc. | -1.29 Million USD | 24321.776% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -241186.154% |
| Immunic, Inc. | -111 Thousand USD | 282687.387% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -1878.504% |
| Veracyte, Inc. | 248.14 Million USD | -26.405% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 104.488% |
| FibroGen, Inc. | 128.9 Million USD | -143.338% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 55615702.837% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 2788.567% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 90.771% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -80535.476% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 11.727% |
| TG Therapeutics, Inc. | 219.1 Million USD | -43.159% |
| Galecto, Inc. | -830 Thousand USD | 37891.807% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 22747.798% |
| Fortrea Holdings Inc. | 424 Million USD | 26.021% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 464.028% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 55421.34% |
| XBiotech Inc. | -1.74 Million USD | 18085.78% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 28409.747% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 774.984% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 515.273% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -327.329% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -1766.762% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 19.373% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 731.805% |
| Vaxxinity, Inc. | -2.23 Million USD | 14140.824% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 4.003% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 2870.014% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -1182.86% |
| NexImmune, Inc. | -1.02 Million USD | 30702.982% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -5808640.741% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 4514.399% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 97.224% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 469479.143% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 8933.343% |
| Ainos, Inc. | -253.73 Thousand USD | 123722.863% |
| Pluri Inc. | 322 Thousand USD | -97313.665% |
| Prothena Corporation plc | -129.2 Million USD | 342.778% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -522.07% |
| Celularity Inc. | 6.75 Million USD | -4543.553% |
| Rallybio Corporation | -150 Thousand USD | 209214.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | 1061.977% |
| MeiraGTx Holdings plc | 287 Thousand USD | -109193.38% |
| Omeros Corporation | -69.77 Million USD | 549.522% |
| Humacyte, Inc. | -76.55 Million USD | 509.761% |
| Immunocore Holdings plc | 248.39 Million USD | -26.282% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 2167.849% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -402.825% |
| Blueprint Medicines Corporation | 236.58 Million USD | -32.584% |
| CalciMedica, Inc. | -58 Thousand USD | 540913.793% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 22096.634% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -979.58% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 11129.255% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 1116.271% |
| Pulmatrix, Inc. | -8.22 Million USD | 3915.961% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 26909.573% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 78714.536% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 178.655% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -11201.113% |
| Cytokinetics, Incorporated | -322.59 Million USD | 197.235% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -36284.431% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 92085.924% |
| Vor Biopharma Inc. | -3.49 Million USD | 9082.589% |
| Roivant Sciences Ltd. | 109.23 Million USD | -187.153% |
| Evogene Ltd. | 1.39 Million USD | -22321.158% |
| ProKidney Corp. | -3.16 Million USD | 9998.138% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 814.32% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -4474.479% |
| CorMedix Inc. | -205.56 Thousand USD | 152692.405% |
| BioLineRx Ltd. | 1.1 Million USD | -28209.747% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 498.714% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 950621.212% |
| Atai Life Sciences N.V. | -5000.00 USD | 6273540.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 257505.69% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 326841.667% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 22682.577% |
| Sagimet Biosciences Inc. | 2 Million USD | -15583.6% |
| MediciNova, Inc. | 979.7 Thousand USD | -31916.985% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 472.006% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 331834.969% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1613.805% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -28.273% |
| Biomea Fusion, Inc. | -4.2 Million USD | 7566.603% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 64.042% |
| Mereo BioPharma Group plc | 7.42 Million USD | -4123.97% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 101284.516% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 2614033.333% |
| Absci Corporation | -41.84 Million USD | 849.533% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 6273540.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 510.711% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 12845.713% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -46.757% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 33433.9% |
| Allakos Inc. | -6.14 Million USD | 5207.833% |
| Imunon, Inc. | -720 Thousand USD | 43665.253% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 554.623% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 34.088% |
| BioAtla, Inc. | -103.73 Million USD | 402.39% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 2749679.243% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 176320.225% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 229.179% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 100959.164% |
| XOMA Corporation | 3.86 Million USD | -8024.113% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 547.559% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -2020.265% |
| aTyr Pharma, Inc. | -2.38 Million USD | 13235.343% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -2417.432% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 1081727.586% |
| Viridian Therapeutics, Inc. | -1 Million USD | 31218.254% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -2412861438.462% |
| Akari Therapeutics, Plc | -4000.00 USD | 7841900.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 50.75% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -160998.671% |
| UroGen Pharma Ltd. | 73.35 Million USD | -327.626% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 1275.066% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -2701639.879% |
| Orgenesis Inc. | -5.72 Million USD | 5578.987% |
| Entera Bio Ltd. | -56 Thousand USD | 560228.571% |
| GH Research PLC | -315 Thousand USD | 99678.413% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 166064.021% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 59847.048% |
| Xencor, Inc. | -85.26 Million USD | 467.901% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 142047.805% |
| Replimune Group, Inc. | -2.65 Million USD | 11914.388% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 31428.478% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -76.375% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -160998.671% |
| Portage Biotech Inc. | -54 Thousand USD | 580974.074% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 331834.969% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 83302.122% |
| OncoCyte Corporation | 413 Thousand USD | -75849.637% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 6978342.492% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 141293793.694% |
| Purple Biotech Ltd. | -196 Thousand USD | 160136.735% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -3397.681% |
| scPharmaceuticals Inc. | 9.78 Million USD | -3106.624% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 3103.095% |
| HilleVax, Inc. | -2.15 Million USD | 14648.794% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 323473.196% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 2090689.176% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 47056.886% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 1363891.304% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 4178961.095% |
| Savara Inc. | -44.26 Million USD | 808.671% |
| Curis, Inc. | 9.81 Million USD | -3097.146% |
| Daré Bioscience, Inc. | 2.76 Million USD | -11225.853% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 251463.913% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 18241.816% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 137675.439% |
| BeiGene, Ltd. | 2.07 Billion USD | 84.911% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 11318.999% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 178.484% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -453.331% |
| Erasca, Inc. | -3.73 Million USD | 8504.93% |
| bluebird bio, Inc. | -4.03 Million USD | 7883.424% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 1111702.523% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 83.529% |
| DBV Technologies S.A. | 15.72 Million USD | -1894.354% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 1111702.523% |
| Moderna, Inc. | 2.15 Billion USD | 85.444% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 34381.093% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -3817.962% |
| Molecular Templates, Inc. | 50.39 Million USD | -522.427% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 58620.896% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -134.455% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 5141.337% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 897.275% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 382.262% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 8842.252% |
| MacroGenics, Inc. | 50.52 Million USD | -520.801% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 5243.85% |
| Prime Medicine, Inc. | -147.9 Million USD | 312.077% |
| Aditxt, Inc. | -111.66 Thousand USD | 281017.07% |
| Adagene Inc. | 18.11 Million USD | -1631.895% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -64177.049% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -123.729% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -98.733% |
| SciSparc Ltd. | 2.19 Million USD | -14183.789% |
| Vericel Corporation | 135.57 Million USD | -131.362% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 1252333.622% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 1012533.026% |
| Generation Bio Co. | -73.91 Million USD | 524.391% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 71878.49% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -474.291% |
| Invivyd, Inc. | -2.02 Million USD | 15567.061% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 204.265% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 303346.389% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -225.494% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -219.136% |
| ADMA Biologics, Inc. | 88.21 Million USD | -255.565% |
| Clene Inc. | 533 Thousand USD | -58750.281% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -1201.048% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 32876.594% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1613.805% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -15678.27% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 161523.66% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -529.8% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 4522.899% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 37620.574% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -276.038% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -428929.434% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -490.03% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 281.116% |
| Trevena, Inc. | 1.45 Million USD | -21458.213% |
| Surrozen, Inc. | -27.23 Million USD | 1251.935% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 88958.924% |
| Cingulate Inc. | -582.91 Thousand USD | 53910.656% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 1011945.161% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 1692.324% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 4143719.551% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 35704.086% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 53.92% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 31848.178% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 556828.551% |
| Kronos Bio, Inc. | 1.37 Million USD | -22762.391% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 684.489% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 107521.918% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 64335.717% |
| ImmunityBio, Inc. | -17.89 Million USD | 1853.337% |
| Korro Bio, Inc. | -3.63 Million USD | 8741.102% |
| Kineta, Inc. | 5.43 Million USD | -5673.458% |
| BioVie Inc. | -229.37 Thousand USD | 136849.543% |
| Codexis, Inc. | 57.33 Million USD | -447.096% |
| Celularity Inc. | 6.75 Million USD | -4543.553% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -7716.397% |
| Celcuity Inc. | -142.77 Thousand USD | 219801.342% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -619927.673% |
| Cibus, Inc. | 1.42 Million USD | -21958.509% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 83969.519% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 1468.611% |
| IN8bio, Inc. | -2.5 Million USD | 12641.863% |
| Kodiak Sciences Inc. | -25.94 Million USD | 1308.895% |
| Annexon, Inc. | -3.26 Million USD | 9701.224% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 15445.988% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 851.544% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -48911.25% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 59.709% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -81.36% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 16609.053% |
| Arcellx, Inc. | 108.27 Million USD | -189.689% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 1069.051% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -296.031% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 1582.943% |
| Moolec Science SA | -143.3 Thousand USD | 218984.198% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 841.226% |
| Geron Corporation | -123.5 Million USD | 353.979% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -9442.805% |
| Royalty Pharma plc | 1.79 Billion USD | 82.515% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 547.527% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 8684263.898% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -135459.291% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 381.537% |
| Humacyte, Inc. | -76.55 Million USD | 509.761% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 33146.839% |
| 89bio, Inc. | -273 Thousand USD | 114998.168% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 25054.018% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 37089.623% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 255117.886% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -27931.457% |
| Notable Labs, Ltd. | 113 Thousand USD | -277485.841% |
| Liquidia Corporation | 14.6 Million USD | -2048.438% |
| Mustang Bio, Inc. | -2.22 Million USD | 14197.618% |
| Immunovant, Inc. | -231 Thousand USD | 135888.745% |
| Quantum-Si incorporated | 488 Thousand USD | -64177.049% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 664.575% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 1045673.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -16745.972% |
| Acasti Pharma Inc. | -11 Thousand USD | 2851663.636% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 153397.136% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 48472.282% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 287.253% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -27546.53% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 82428.609% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 16120.02% |
| PepGen Inc. | -1.18 Million USD | 26592.568% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 247085.827% |
| United Therapeutics Corporation | 2.07 Billion USD | 84.847% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 1469.926% |
| Solid Biosciences Inc. | -76.56 Million USD | 509.691% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 379926.357% |
| Immuneering Corporation | -764.13 Thousand USD | 41149.13% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -473267.138% |
| Belite Bio, Inc | -399 Thousand USD | 78714.536% |
| XOMA Corporation | 3.86 Million USD | -8024.113% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 1665.542% |
| Bionomics Limited | -434.44 Thousand USD | 72299.959% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 29305.959% |
| uniQure N.V. | 2.21 Million USD | -14061.264% |
| Cassava Sciences, Inc. | -89.42 Million USD | 450.773% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 440.692% |
| Forte Biosciences, Inc. | -9000.00 USD | 3485344.444% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 37665.509% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 71878.49% |
| Altimmune, Inc. | -65.37 Million USD | 579.819% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 13.357% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 29305.959% |
| Compugen Ltd. | 31.45 Million USD | -897.209% |
| Peak Bio, Inc. | 367.76 Thousand USD | -85190.495% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -1179.458% |
| Benitec Biopharma Inc. | 108 Thousand USD | -290337.037% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 402243.59% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 26174.148% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 17315.807% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 263689.916% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 26174.148% |
| Instil Bio, Inc. | -4.75 Million USD | 6695.29% |
| argenx SE | 1.1 Billion USD | 71.703% |
| Immunome, Inc. | -8.9 Million USD | 3621.635% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 16696.402% |
| Verona Pharma plc | -679.62 Thousand USD | 46253.756% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 179341.143% |
| Shattuck Labs, Inc. | -2.38 Million USD | 13251.866% |
| CervoMed Inc. | -1.29 Million USD | 24347.484% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 13131.658% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 6666.297% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -12594.132% |
| Moolec Science SA | -143.3 Thousand USD | 218984.198% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 76974.74% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 11841.296% |
| AnaptysBio, Inc. | 14.78 Million USD | -2022.13% |
| Design Therapeutics, Inc. | -537 Thousand USD | 58511.918% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 73559.485% |
| NeurAxis, Inc. | 2.15 Million USD | -14444.045% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -14516.589% |
| Lumos Pharma, Inc. | 2 Million USD | -15528.899% |
| Achilles Therapeutics plc | -4.73 Million USD | 6729.767% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 179341.143% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 296927.064% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -890.791% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -36284.431% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 30494.574% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 788.663% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -729369.767% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 38259.611% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 2383988.129% |
| Palisade Bio, Inc. | 246 Thousand USD | -127408.943% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 950621.212% |
| Beam Therapeutics Inc. | -59.67 Million USD | 625.66% |
| Neurogene Inc. | -3.26 Million USD | 9715.941% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -125.121% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 8595.991% |
| Sesen Bio, Inc. | 40 Million USD | -684.18% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 105713.468% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 7889.151% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 3379.03% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -2127.784% |
| Athira Pharma, Inc. | -969 Thousand USD | 32470.691% |
| Vaccinex, Inc. | -16 Million USD | 2059.96% |
| HCW Biologics Inc. | -574.82 Thousand USD | 54668.355% |
| XOMA Corporation | 3.86 Million USD | -8024.113% |
| Nektar Therapeutics | 53.47 Million USD | -486.544% |
| Arvinas, Inc. | 71.8 Million USD | -336.869% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 475.831% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 599.677% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 97513.665% |
| Rezolute, Inc. | -36 Thousand USD | 871411.111% |
| Clene Inc. | 533 Thousand USD | -58750.281% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 24429383.489% |
| BeyondSpring Inc. | 1.75 Million USD | -17813.878% |
| Synlogic, Inc. | -1.92 Million USD | 16403.119% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 847862.162% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 5053.759% |
| Peak Bio, Inc. | 367.76 Thousand USD | -85190.495% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 1754.126% |
| Krystal Biotech, Inc. | 47.6 Million USD | -558.906% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -122.319% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -6142.229% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 12214.541% |
| MannKind Corporation | 136.19 Million USD | -130.318% |
| Ikena Oncology, Inc. | -50.49 Million USD | 721.231% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -188.264% |
| Gossamer Bio, Inc. | -4.38 Million USD | 7253.295% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 124573.016% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 6273540.0% |
| Legend Biotech Corporation | 140.92 Million USD | -122.574% |
| Mural Oncology plc | -2.56 Million USD | 12319.4% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 57027.768% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 313772.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -1411.381% |
| REGENXBIO Inc. | 53.02 Million USD | -491.51% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 5955.418% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 163152.372% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 18210.393% |
| Vaxart, Inc. | -60.76 Million USD | 616.222% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 119466.771% |
| Cellectis S.A. | 18 Thousand USD | -1742522.222% |
| Longeveron Inc. | 221 Thousand USD | -141833.032% |
| Repare Therapeutics Inc. | -80.07 Million USD | 491.747% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 71.302% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 24340.495% |
| Revolution Medicines, Inc. | -399.66 Million USD | 178.484% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 896305.714% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -640046.939% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 96.356% |
| Denali Therapeutics Inc. | -93.34 Million USD | 436.035% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 1252333.622% |
| Veru Inc. | 7.56 Million USD | -4045.85% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 207829.801% |
| Cingulate Inc. | -582.91 Thousand USD | 53910.656% |
| Passage Bio, Inc. | -3.72 Million USD | 8529.777% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 2604483.926% |
| Exicure, Inc. | -1.42 Million USD | 22143.008% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 81998.695% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -11504.587% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 61283.401% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -360.429% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 209763.986% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 629.798% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -80123.018% |
| OmniAb, Inc. | 14.66 Million USD | -2038.624% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -1468.909% |
| Lipocine Inc. | -2.85 Million USD | 11102.877% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 17119.642% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 5598.195% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 20924.13% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -316.475% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 482672.308% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -272.108% |
| Ocugen, Inc. | -33.53 Million USD | 1035.301% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 10020.051% |
| Q32 Bio Inc. | 578 Thousand USD | -54168.512% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 118466.792% |
| Alumis Inc. Common Stock | -1.28 Million USD | 24529.283% |
| Equillium, Inc. | 35.95 Million USD | -772.329% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 18475.63% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -62549.322% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 7587714.901% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 121208.88% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -74104.659% |
| Dominari Holdings Inc. | 2.03 Million USD | -15283.619% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 171065.439% |
| vTv Therapeutics Inc. | -13.59 Million USD | 2407.26% |
| Bio-Techne Corporation | 773.07 Million USD | 59.425% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -1711.144% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 31.927% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 26932.506% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 1408.057% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -2581.645% |
| Nkarta, Inc. | -5.86 Million USD | 5444.556% |
| BioCardia, Inc. | -7.24 Million USD | 4427.107% |
| Iterum Therapeutics plc | -1.75 Million USD | 18024.114% |